Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Proffered Paper Session 1

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Proffered Paper Session 1
Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange
Michael Burns
Vanderbilt University School of Medicine, Nashville, TN, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
Proffered Paper Session 1
  •  
  • Permission not
    granted for presentation
  •  
  •  
LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6-- Reactivating Rb in cancer
Sunkyu Kim
Novartis Institutes for Biomedical Research, Cambridge, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
Proffered Paper Session 1
  •  
  • Permission not
    granted for presentation
  •  
  •  
Selective sensitization of mutant K-Ras cancer cells to DNA damage based therapies by targeting wild type H- and N-Ras
Elda Grabocka
NYU Langone Medical Center, New York, NY, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
Proffered Paper Session 1
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
Katherine Hutchinson
Vanderbilt University, Nashville, TN, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4